Intent: To welcome and highlight the value of the new IPHA Framework Agreement on Pricing & Supply of Medicines and its potential to improve access to innovation for patients::To encourage collaborative implementation of the Framework Agreement in the coming months and years
Intent: Engagement with relevant stakeholders in relation to negotiations for a new Framework Agreement on the Supply and Pricing of Medicines, noting the priorities of MFI members, and concluding an agreement that ensures the supply of affordable and accessible medicines for Irish patients.
Details: Engagement with officials in relation to the Framework Agreement on the Supply and Pricing of Medicines
Intent: Share correspondence on behalf of Medicines for Ireland with relevant political representatives and stakeholders regarding the possibility of supply chain disruption due to fuel protests, ensuring that medicines can continue to be manufactured, transported, exported and supplied to patients.
Details: Correspondence to relevant stakeholders regarding possible supply chain disruption
Intent: Engagement with Health interested TDs to:- Highlight the potential patient and health system impact/cost resulting from removing low dose codeine containing products from OTC use in Ireland. - Share/raise a range of procedural concerns relating to the review process adopted.- Facilitate political scrutiny of a significant potential public policy development, in the interest of safeguarding patient choice, self-care and the clinical autonomy of pharmacists.
Details: HPRA formal regulatory procedure to determine the appropriate method of sale for authorised codeine-containing medicines in Ireland
Email sent about this matter to officers of the Oireachtas' Joint Committee on Health and opposition cross-party Health spokespeople.- David Cullinane, TD – SF spokesperson on health- Padraig Rice, TD – Social Democrat spokesperson for Health/Chair Joint Committee on Health- Marie Sherlock, TD – Labour Party Spokesperson on Health- Colm Burke, TD – FG TD/Deputy Chair of Committee - EmailLetters on this topic sent to the following Ministers and officials: - Dr. Jennifer Carroll MacNeill, Minister for Health - Jennifer Murnane O’Connor, Minister of State with responsibility for Public Health, Wellbeing and the National Drugs Strategy - Emer Higgins, TD – Minister of State with responsibility for Disability. - Niall Redmond, Assistant Secretary,Primary Care Oversight & Performance - LetterMeetings held on this topic with two TDs: - David Cullinane, TD – SF Spokesperson on Health. 17th Feb, 2.20pm.- Colm Burke TD - FG Deputy Chair of Committee. 12th Feb, 11am. Tabled PQ’s on the topic as a result of the meeting. - Virtual Meeting
Intent: This would allow for “Direct Access”, meaning the auxiliary dental worker, the Dental Hygienist, to provide preventative dental treatment within their scope of practice without the dentist's prior supervision, prior examination and indicated treatment. Direct Access would help reduce the backlog of primary school children in Ireland who have not had any dental screening and, and enable better access to and choice of preventive dental care for the Irish population.
Details: The Irish Dental Hygienist Association (IDHA) are Lobbying To Amend The Dental Act,1985 to remove: Section 54 (2) “Dental work carried out by an auxiliary dental worker in accordance with a scheme made by the Council under section 53 of the Act
Email to the Minister of Health, Jennifer Carroll MacNeill, to ask on Progress of our request for an immediate amendment to the Dental Act - EmailFEBRUARY 19TH 2026, IDHA’s Submission for Direct Access to the Oireachtas Health Committee. - SubmissionMARCH 15th 2026, IDHA President, Political Opinion Piece on Direct Access published in the Irish Examiner - Social Media
Intent: Engagement with relevant stakeholders in relation to negotiations for a new Framework Agreement on the Supply and Pricing of Medicines, noting the priorities of MFI members, and the need to deliver an agreement that ensures the supply of affordable and accessible medicines for Irish patients.
Details: Engagement with officials in relation to the Framework Agreement on the Supply and Pricing of Medicines
Intent: (1) Ensuring awareness of impact of potential reforms of tariffs to supply and manufacturing of critical medicines. (2) Provide an insight from an American perspective on matters relating to EU-US trade, tariffs and medicines pricing.